Randomised Study of Evolocumab in Patients With Type 2 Diabetes and Dyslipidaemia on Background Statin: Primary Results of the BERSON Clinical Trial
Diabetes, Obesity and Metabolism - United Kingdom
doi 10.1111/dom.13680
Full Text
Open PDFAbstract
Available in full text
Date
April 2, 2019
Authors
Publisher
Wiley